Cardinal Health第四季度收益超出预期，受药品销售增长和销售增长的推动。 Cardinal Health Q4 earnings exceeded expectations, driven by increased pharmaceutical sales and sales growth.

红衣主教健康公司报告的Q4收入比预期的要好,经过调整的EPS年增长29%,达到1.84美元,这是由强劲的药品销售驱动的。 Cardinal Health Inc reported better-than-expected Q4 earnings, with a 29% year-over-year increase in adjusted EPS to $1.84, driven by robust pharmaceutical sales. 保健服务提供者的销售额增加了12%,达到59.87bn。 The healthcare services provider's sales increased by 12% to $59.87bn. 作为回应,卡迪纳尔健康公司提高了全年利预期和股票回购计划,预计全年调整的每股收益将在7.55美元至7.70美元之间. In response, Cardinal Health raised its full-year profit guidance and share repurchase plan, projecting full-year adjusted EPS to range between $7.55 and $7.70.